Journal
TISSUE ENGINEERING PART C-METHODS
Volume 19, Issue 3, Pages 189-195Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/ten.tec.2012.0307
Keywords
-
Categories
Funding
- Liver Group Charity
- Wellcome Trust [066327]
- Engineering and Physical Sciences Research Council [GR/S04550/01] Funding Source: researchfish
- Medical Research Council [MR/K500720/1] Funding Source: researchfish
Ask authors/readers for more resources
Introduction: A bioartificial liver comprising alginate-encapsulated liver cell spheroids (ELS) could bridge the gap to transplant or spontaneous recovery in acute liver failure, but will be required for emergency use, necessitating cryopreservation. A cryopreservation protocol has been developed, but beyond this, the feasibility of cold-chain storage is considered here. Cryopreservation will be increasingly required for timely delivery of tissue and bioengineered products, and significant, but often, over-looked factors that impact on cost and ease of clinical application are the storage temperature and useful preservation time. Storage in the vapor phase of liquid nitrogen (similar to-170 degrees C) is the gold standard, but for safety and economic purposes, storing ELS in electric freezers at -80 degrees C may be preferable. Methods: ELS were cryopreserved using an optimized protocol and stored at either -80 degrees C or at -170 degrees C for up to 1 year. ELS were removed from storage after 1, 2, 3, 6, 9, or 12 months, and recovery was assessed 24 h postwarming. Cell recovery was assessed using viability (fluorescent staining with image analysis), cell number (nuclei count), and functional (hepatospecific protein enzyme-linked immunosorbent assay) assays. Results: Viability, the viable cell number, and function of ELS stored at -170 degrees C were maintained at similar values throughout the year. In contrast, ELS stored at -80 degrees C exhibited decreased viability, viable cell numbers, and function by as early as 1 month. Progressive deterioration was subsequently observed. After 12 months of storage at -80 degrees C, viable cell recovery of ELS was similar to 15% that of ELS stored at -170 degrees C. Conclusions: While convenience and cost might support the use of -80 degrees C for storage of multicellular bioengineered products such as ELS, results indicate rapid deterioration in functional recoveries after only a few weeks. This study demonstrates that storage temperature is an important consideration in regenerative medicine and caution should be applied by limiting storage at -80 degrees C to only a few weeks.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available